Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Boule Diagnostics AB

Market Cap 131M 13.46M 11.83M 10.9M 10.2M 19.12M 1.28B 19.44M 50.66M 626M 50.54M 49.46M 2.18B P/E 2026 *
-13.4x
P/E 2027 * 15.2x
Enterprise Value 327M 33.69M 29.59M 27.27M 25.53M 47.83M 3.19B 48.63M 127M 1.57B 126M 124M 5.44B EV / Sales 2026 *
0.72x
EV / Sales 2027 * 0.65x
Free-Float
50.4%
Yield 2026 *
-
Yield 2027 * -
1 day+2.67%
1 week+4.53%
Current month+4.22%
1 month-1.70%
3 months-13.07%
6 months-30.24%
Current year-29.53%
1 week 3.15
Extreme 3.15
3.67
1 month 3.09
Extreme 3.09
3.79
Current year 3.09
Extreme 3.09
5.68
1 year 3.09
Extreme 3.09
10.6
3 years 3.09
Extreme 3.09
12.62
5 years 3.09
Extreme 3.09
61.9
10 years 3.09
Extreme 3.09
108.88
Manager TitleAgeSince
Chief Executive Officer - 2026-06-21
Director of Finance/CFO 54 2026-02-10
Chief Executive Officer - 2024-04-15
Director TitleAgeSince
Chairman 73 2020-12-31
Chairman 74 2022-12-31
Director/Board Member 59 2013-12-31
Date Insider Type Main position Quantity % Market Cap.
23-02-26Buy

Chief Financial Officer

8,000 0.0206%
23-02-05Buy

Director

7,083 0.0182%
22-02-16Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+2.67%+4.53%-55.75%-68.88% 13.63M
+0.76%-1.39%+16.46%-11.09% 172B
-0.16%-3.85%-22.15%+22.53% 143B
+0.41%-1.47%-8.99%-24.98% 126B
+2.15%-3.57%-55.80%-16.17% 65.89B
+0.59%-2.70%+14.43%-4.59% 49.45B
+0.06%-2.21%-25.84%-32.63% 44.05B
+0.41%-1.18%+9.21%+6.20% 35.72B
-0.66%-1.46%+3.63%+36.72% 35.18B
+4.79%+0.11%-11.05%-20.70% 27.58B
Average +1.09%-2.09%-13.59%-11.36% 69.92B
Weighted average by Cap. +0.65%-2.43%-7.73%-5.20%

Financials

2026 *2027 *
Net sales 453M 46.62M 40.95M 37.74M 35.33M 66.19M 4.42B 67.3M 175M 2.17B 175M 171M 7.53B 483M 49.73M 43.68M 40.25M 37.68M 70.6M 4.71B 71.79M 187M 2.31B 187M 183M 8.03B
Net income -9.77M -1.01M -883K -814K -762K -1.43M -95.25M -1.45M -3.78M -46.73M -3.77M -3.69M -162M 8.6M 884K 777K 716K 670K 1.26M 83.78M 1.28M 3.33M 41.11M 3.32M 3.25M 143M
Net Debt 197M 20.22M 17.76M 16.37M 15.32M 28.71M 1.92B 29.19M 76.08M 940M 75.91M 74.28M 3.27B 185M 18.98M 16.68M 15.37M 14.39M 26.95M 1.8B 27.41M 71.43M 882M 71.26M 69.73M 3.07B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
26-06-23 SEK 3.460 +2.67% 22,527
26-06-22 SEK 3.370 +5.31% 49,147
26-06-18 SEK 3.200 -3.03% 10,671
26-06-17 SEK 3.300 -0.30% 6,454
26-06-16 SEK 3.310 -0.30% 1,990
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.370SEK
Average target price
3.800SEK
Spread / Average Target
+12.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!